PTGS2 and rheumatoid arthritis: Currently, the available primary choices for the treatment of RA are opioids, cyclooxygenase-2 (COX-2) inhibitors, non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), and analgesics (Seo et al., 2022).